Teijo I. Saari

2.9k total citations · 1 hit paper
63 papers, 2.0k citations indexed

About

Teijo I. Saari is a scholar working on Anesthesiology and Pain Medicine, Pharmacology and Pharmacology. According to data from OpenAlex, Teijo I. Saari has authored 63 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Anesthesiology and Pain Medicine, 16 papers in Pharmacology and 16 papers in Pharmacology. Recurrent topics in Teijo I. Saari's work include Anesthesia and Sedative Agents (27 papers), Pain Management and Opioid Use (21 papers) and Pharmacogenetics and Drug Metabolism (14 papers). Teijo I. Saari is often cited by papers focused on Anesthesia and Sedative Agents (27 papers), Pain Management and Opioid Use (21 papers) and Pharmacogenetics and Drug Metabolism (14 papers). Teijo I. Saari collaborates with scholars based in Finland, Germany and United States. Teijo I. Saari's co-authors include Klaus T. Olkkola, Nora Hagelberg, Pertti J. Neuvonen, Marko Peltoniemi, Kari Laine, Mikko Neuvonen, Harald Ihmsen, Juha Grönlund, Jouni Ahonen and Krista Laine and has published in prestigious journals such as PLoS ONE, Scientific Reports and Pharmacological Reviews.

In The Last Decade

Teijo I. Saari

60 papers receiving 2.0k citations

Hit Papers

Ketamine: A Review of Clinical Pharmacokinetics and Pharm... 2016 2026 2019 2022 2016 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Ketamine: A Review of Clinical Pharmacokinetics and Pharmacodynamics in Anesthesia and Pain Therapy
    2016 422 citations Marko Peltoniemi, Nora Hagelberg et al. Clinical Pharmacokinetics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Teijo I. Saari Finland 27 914 583 478 362 318 63 2.0k
David R. Drover United States 32 1.3k 1.5× 359 0.6× 73 0.2× 522 1.4× 933 2.9× 97 3.0k
W.S. Nimmo United Kingdom 27 1.5k 1.6× 689 1.2× 223 0.5× 376 1.0× 1.2k 3.8× 72 3.7k
Janet K. Coller Australia 28 354 0.4× 305 0.5× 632 1.3× 426 1.2× 190 0.6× 78 2.4k
Thomas K. Henthorn United States 28 701 0.8× 423 0.7× 207 0.4× 322 0.9× 509 1.6× 86 2.0k
Carsten Skarke Germany 26 590 0.6× 433 0.7× 412 0.9× 512 1.4× 379 1.2× 64 2.4k
Ann Locniskar United States 17 514 0.6× 251 0.4× 343 0.7× 255 0.7× 192 0.6× 39 1.6k
Jaakko‐Juhani Himberg Finland 24 398 0.4× 123 0.2× 275 0.6× 199 0.5× 320 1.0× 56 1.9k
France Varin Canada 26 721 0.8× 332 0.6× 113 0.2× 137 0.4× 882 2.8× 103 2.2k
E Iisalo Finland 24 409 0.4× 273 0.5× 187 0.4× 415 1.1× 415 1.3× 128 2.3k
Joseph M. Scavone United States 21 294 0.3× 306 0.5× 169 0.4× 285 0.8× 116 0.4× 44 1.3k

Countries citing papers authored by Teijo I. Saari

Since Specialization
Citations

This map shows the geographic impact of Teijo I. Saari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Teijo I. Saari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Teijo I. Saari more than expected).

Fields of papers citing papers by Teijo I. Saari

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Teijo I. Saari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Teijo I. Saari. The network helps show where Teijo I. Saari may publish in the future.

Co-authorship network of co-authors of Teijo I. Saari

This figure shows the co-authorship network connecting the top 25 collaborators of Teijo I. Saari. A scholar is included among the top collaborators of Teijo I. Saari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Teijo I. Saari. Teijo I. Saari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
4.
Mäkelä, Keijo, et al.. (2020). Intranasal Dexmedetomidine Reduces Postoperative Opioid Requirement in Patients Undergoing Total Knee Arthroplasty Under General Anesthesia. The Journal of Arthroplasty. 36(3). 978–985.e1. 14 indexed citations
5.
Uusalo, Panu, et al.. (2020). Population Modelling of Dexmedetomidine Pharmacokinetics and Haemodynamic Effects After Intravenous and Subcutaneous Administration. Clinical Pharmacokinetics. 59(11). 1467–1482. 9 indexed citations
6.
Uusalo, Panu, et al.. (2019). Intranasal Low-Dose Dexmedetomidine Reduces Postoperative Opioid Requirement in Patients Undergoing Hip Arthroplasty Under General Anesthesia. The Journal of Arthroplasty. 34(4). 686–692.e2. 18 indexed citations
7.
Li, Xia, Sebastian Frechen, Thorsten Lehr, et al.. (2019). A Physiologically Based Pharmacokinetic Model of Voriconazole Integrating Time-Dependent Inhibition of CYP3A4, Genetic Polymorphisms of CYP2C19 and Predictions of Drug–Drug Interactions. Clinical Pharmacokinetics. 59(6). 781–808. 46 indexed citations
8.
Hagelberg, Nora, Janne T. Backman, Jouko Laitila, et al.. (2018). Voriconazole greatly increases the exposure to oral buprenorphine. European Journal of Clinical Pharmacology. 74(12). 1615–1622. 11 indexed citations
9.
Uusalo, Panu, et al.. (2018). Subcutaneously administered dexmedetomidine is efficiently absorbed and is associated with attenuated cardiovascular effects in healthy volunteers. European Journal of Clinical Pharmacology. 74(8). 1047–1054. 26 indexed citations
10.
Ihmsen, Harald & Teijo I. Saari. (2012). Dexmedetomidin. Der Anaesthesist. 61(12). 1059–1066. 30 indexed citations
11.
Saari, Teijo I., J. Fechner, Harald Ihmsen, J. Schüttler, & Christian Jeleazcov. (2012). Determination of total and unbound sufentanil in human plasma by ultrafiltration and LC–MS/MS: Application to clinical pharmacokinetic study. Journal of Pharmaceutical and Biomedical Analysis. 66. 306–313. 23 indexed citations
12.
Jeleazcov, Christian, Teijo I. Saari, Harald Ihmsen, J. Schüttler, & J. Fechner. (2012). Changes in total and unbound concentrations of sufentanil during target controlled infusion for cardiac surgery with cardiopulmonary bypass. British Journal of Anaesthesia. 109(5). 698–706. 22 indexed citations
13.
Peltoniemi, Marko, Teijo I. Saari, Nora Hagelberg, et al.. (2011). St John’s wort greatly decreases the plasma concentrations of oral S‐ketamine. Fundamental and Clinical Pharmacology. 26(6). 743–750. 27 indexed citations
14.
Saari, Teijo I., Petri Reponen, Miia Turpeinen, et al.. (2011). Exposure to Oral S-ketamine Is Unaffected by Itraconazole but Greatly Increased by Ticlopidine. Clinical Pharmacology & Therapeutics. 90(2). 296–302. 36 indexed citations
15.
Saari, Teijo I., Harald Ihmsen, Pertti J. Neuvonen, Klaus T. Olkkola, & H. Schwilden. (2011). Oxycodone clearance is markedly reduced with advancing age: a population pharmacokinetic study. British Journal of Anaesthesia. 108(3). 491–498. 46 indexed citations
16.
Grönlund, Juha, Teijo I. Saari, Nora Hagelberg, et al.. (2010). Exposure to oral oxycodone is increased by concomitant inhibition of CYP2D6 and 3A4 pathways, but not by inhibition of CYP2D6 alone. British Journal of Clinical Pharmacology. 70(1). 78–87. 61 indexed citations
17.
Saari, Teijo I. & Klaus T. Olkkola. (2010). Azole antimycotics and drug interactions in the perioperative period. Current Opinion in Anaesthesiology. 23(4). 441–448. 5 indexed citations
18.
Hagelberg, Nora, Teijo I. Saari, Mikko Neuvonen, et al.. (2010). Oxycodone concentrations are greatly increased by the concomitant use of ritonavir or lopinavir/ritonavir. European Journal of Clinical Pharmacology. 66(10). 977–985. 49 indexed citations
19.
Saari, Teijo I., Kirsi Jahnukainen, & Pasi Pöllänen. (1996). Autoantigenicity of the basal compartment of seminiferous tubules in the rat. Journal of Reproductive Immunology. 31(1-2). 65–79. 15 indexed citations
20.
Saari, Teijo I., et al.. (1996). CD28–CD80/CD86 Interactions in testicular immunoregulation. Journal of Reproductive Immunology. 31(3). 145–163. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David R. Drover Breakdown of academic impact, for papers by W.S. Nimmo Breakdown of academic impact, for papers by Janet K. Coller Breakdown of academic impact, for papers by Thomas K. Henthorn Breakdown of academic impact, for papers by Carsten Skarke Breakdown of academic impact, for papers by Ann Locniskar Breakdown of academic impact, for papers by Jaakko‐Juhani Himberg Breakdown of academic impact, for papers by France Varin Breakdown of academic impact, for papers by E Iisalo Breakdown of academic impact, for papers by Joseph M. Scavone
Rankless by CCL
2026